Ultragenyx Pharmaceutical Inc. (RARE)
USD 31.01
(-4.38%)
USD 31.01
(-4.38%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 389.04 Million USD | 16.13% |
| 2022 | 335 Million USD | -0.12% |
| 2021 | 335.39 Million USD | 26.61% |
| 2020 | 264.9 Million USD | 179.71% |
| 2019 | 94.7 Million USD | 88.1% |
| 2018 | 50.34 Million USD | 1828.34% |
| 2017 | 2.61 Million USD | 101.43% |
| 2016 | -183.07 Million USD | -13127.67% |
| 2015 | -1.38 Million USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 116.88 Million USD | 41.75% |
| 2024 Q1 | 82.45 Million USD | -28.51% |
| 2023 FY | 389.04 Million USD | 16.13% |
| 2023 Q3 | 87.06 Million USD | -11.51% |
| 2023 Q1 | 88.23 Million USD | -9.99% |
| 2023 Q2 | 98.39 Million USD | 11.51% |
| 2023 Q4 | 115.34 Million USD | 32.48% |
| 2022 Q3 | 82.07 Million USD | 1.23% |
| 2022 Q4 | 98.02 Million USD | 19.44% |
| 2022 FY | 335 Million USD | -0.12% |
| 2022 Q1 | 73.83 Million USD | -7.57% |
| 2022 Q2 | 81.07 Million USD | 9.8% |
| 2021 Q4 | 79.88 Million USD | 3.11% |
| 2021 FY | 335.39 Million USD | 26.61% |
| 2021 Q1 | 94.2 Million USD | 9.47% |
| 2021 Q2 | 83.83 Million USD | -11.01% |
| 2021 Q3 | 77.47 Million USD | -7.59% |
| 2020 Q2 | 59.9 Million USD | 181.9% |
| 2020 Q4 | 86.06 Million USD | 8.77% |
| 2020 Q1 | -73.14 Million USD | -339.94% |
| 2020 FY | 264.9 Million USD | 179.71% |
| 2020 Q3 | 79.12 Million USD | 32.08% |
| 2019 Q2 | 23.38 Million USD | 31.96% |
| 2019 FY | 94.7 Million USD | 88.1% |
| 2019 Q1 | 17.72 Million USD | 12.48% |
| 2019 Q4 | 30.48 Million USD | 31.88% |
| 2019 Q3 | 23.11 Million USD | -1.14% |
| 2018 Q3 | 11.49 Million USD | -9.19% |
| 2018 FY | 50.34 Million USD | 1828.34% |
| 2018 Q1 | 10.45 Million USD | 333.15% |
| 2018 Q2 | 12.65 Million USD | 21.06% |
| 2018 Q4 | 15.75 Million USD | 37.11% |
| 2017 FY | 2.61 Million USD | 101.43% |
| 2017 Q1 | -51.26 Million USD | -1.04% |
| 2017 Q2 | -58.43 Million USD | -13.98% |
| 2017 Q3 | -60.21 Million USD | -3.04% |
| 2017 Q4 | 2.41 Million USD | 104.01% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q4 | -50.74 Million USD | -4.41% |
| 2016 Q3 | -48.6 Million USD | -12.2% |
| 2016 Q2 | -43.31 Million USD | 0.0% |
| 2016 FY | -183.07 Million USD | -13127.67% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 FY | -1.38 Million USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -923.116% |
| Alkermes plc | 1.37 Billion USD | 71.7% |
| Agenus Inc. | 139.61 Million USD | -178.652% |
| Aptorum Group Limited | -1.11 Million USD | 35001.246% |
| Ardelyx, Inc. | 106.66 Million USD | -264.744% |
| Dyadic International, Inc. | 922.95 Thousand USD | -42051.476% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -1747.206% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 222608.193% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 3012.445% |
| Novavax, Inc. | 639.93 Million USD | 39.207% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 930.59% |
| Pyxis Oncology, Inc. | -2 Million USD | 19552.0% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 75386.504% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -1942.955% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 880520.024% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 73921.632% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 496.103% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -48408.728% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 474539.024% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -187.605% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -4842.701% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 501.279% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 74.37% |
| AlloVir, Inc. | -398 Thousand USD | 97848.744% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | -61.605% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -91654.717% |
| Bicycle Therapeutics plc | -129.52 Million USD | 400.371% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -324100.0% |
| ChromaDex Corporation | 50.78 Million USD | -666.128% |
| Chimerix, Inc. | 324 Thousand USD | -119974.074% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 1348.217% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 601.353% |
| CRISPR Therapeutics AG | 240.95 Million USD | -61.457% |
| Precision BioSciences, Inc. | 40.47 Million USD | -861.257% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 496.32% |
| Fortress Biotech, Inc. | 57.85 Million USD | -572.463% |
| Fortress Biotech, Inc. | 57.85 Million USD | -572.463% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -2246.866% |
| ImmuCell Corporation | 4.39 Million USD | -8749.292% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 466.593% |
| Immix Biopharma, Inc. | -5468.00 USD | 7114950.037% |
| Incyte Corporation | 3.44 Billion USD | 88.693% |
| Innoviva, Inc. | 261.06 Million USD | -49.02% |
| IO Biotech, Inc. | -756 Thousand USD | 51560.317% |
| Jaguar Health, Inc. | 7.72 Million USD | -4936.769% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 58690.361% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -224.869% |
| ContextLogic Inc. | 59 Million USD | -559.39% |
| MiMedx Group, Inc. | 266.84 Million USD | -45.794% |
| MEI Pharma, Inc. | 49.32 Million USD | -688.696% |
| NextCure, Inc. | -3.68 Million USD | 10660.261% |
| Onconetix, Inc. | -1.12 Million USD | 34614.911% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 1442.999% |
| Opthea Limited | 21.72 Thousand USD | -1791060.221% |
| Psyence Biomedical Ltd. | -240.00 USD | 162100100.0% |
| Vaxcyte, Inc. | -75 Million USD | 618.72% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 678744.943% |
| Precigen, Inc. | 106 Thousand USD | -366918.868% |
| Pharming Group N.V. | 220.1 Million USD | -76.753% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -75441.748% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -38456.987% |
| PureTech Health plc | -1.6 Million USD | 24369.495% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -254.407% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 314.456% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 958.334% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 1869.409% |
| Acelyrin, Inc. | -115 Thousand USD | 338395.652% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 3870759.636% |
| Summit Therapeutics Inc. | -2.05 Million USD | 19077.561% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 68233.1% |
| Senti Biosciences, Inc. | -2.68 Million USD | 14600.186% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -9503.555% |
| Elevation Oncology, Inc. | -39 Thousand USD | 997638.462% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 8208.378% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 9968.982% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -1235.576% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -78335.484% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 707445.455% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -273.721% |
| Seer, Inc. | 7.02 Million USD | -5436.36% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -8786.249% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -1705.709% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 328428.734% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 271584.498% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -63781.773% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -222.924% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | -24.028% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 7780900.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -15014.219% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 766832.361% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -1223.851% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 167789.655% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 79173.171% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 5580.981% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 82081.688% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 3740869.231% |
| Soligenix, Inc. | 97.31 Thousand USD | -399690.363% |
| Century Therapeutics, Inc. | -10.8 Million USD | 3699.223% |
| Kura Oncology, Inc. | -849 Thousand USD | 45923.322% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 679.757% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 264753.061% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -292.815% |
| Autolus Therapeutics plc | -4.86 Million USD | 8093.425% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -840.028% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 231671.429% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -310.713% |
| GRI Bio, Inc. | 10.84 Million USD | -3488.599% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -15216.62% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 4578.416% |
| IGM Biosciences, Inc. | -211.66 Million USD | 283.804% |
| INmune Bio, Inc. | 155 Thousand USD | -250893.548% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -528.102% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 25927.679% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 60095.004% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 1329060.853% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -96676.119% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 19590.982% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 124393.93% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -311.853% |
| Verastem, Inc. | -62 Thousand USD | 627583.871% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -15877.002% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 149157.471% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -12752.329% |
| Histogen Inc. | 3.76 Million USD | -10222.101% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -67420.684% |
| Surrozen, Inc. | -27.23 Million USD | 1528.718% |
| Organovo Holdings, Inc. | -5.38 Million USD | 7319.15% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 32388.693% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 1616.903% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -1840.156% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 19648584.848% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -6313.005% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 579623.618% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | -151.332% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -266731.276% |
| Apollomics, Inc. | 127 Thousand USD | -306230.709% |
| Amarin Corporation plc | 165.54 Million USD | -135.011% |
| Mesoblast Limited | -9.81 Million USD | 4063.729% |
| Turnstone Biologics Corp. | 16.5 Million USD | -2256.961% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 452.107% |
| Synaptogenix, Inc. | -6347.00 USD | 6129610.005% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 762923.529% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | -141.093% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 77.866% |
| Better Therapeutics, Inc. | -2.72 Million USD | 14355.771% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 446.859% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | -15.073% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 3410338.429% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 6314.696% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 35211.913% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -5216.206% |
| Insmed Incorporated | 239.63 Million USD | -62.347% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -10773.113% |
| OmniAb, Inc. | 14.66 Million USD | -2552.485% |
| Alector, Inc. | -95.05 Million USD | 509.287% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -209.693% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 995.106% |
| Zai Lab Limited | 170.9 Million USD | -127.638% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -375.152% |
| Aura Biosciences, Inc. | -1.29 Million USD | 30141.699% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -299161.538% |
| Immunic, Inc. | -111 Thousand USD | 350586.486% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -2353.892% |
| Veracyte, Inc. | 248.14 Million USD | -56.777% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 105.566% |
| FibroGen, Inc. | 128.9 Million USD | -201.806% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 68978823.404% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 3434.566% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 88.553% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -99910.283% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | -9.482% |
| TG Therapeutics, Inc. | 219.1 Million USD | -77.556% |
| Galecto, Inc. | -830 Thousand USD | 46972.289% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 28189.531% |
| Fortrea Holdings Inc. | 424 Million USD | 8.245% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 551.495% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 68713.757% |
| XBiotech Inc. | -1.74 Million USD | 22407.339% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 35211.913% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 937.167% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 615.053% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -430.006% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -2215.301% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 883.612% |
| Vaxxinity, Inc. | -2.23 Million USD | 17514.503% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | -19.063% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 3535.583% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -1491.101% |
| NexImmune, Inc. | -1.02 Million USD | 38056.159% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -7204344.444% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 5575.075% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 96.558% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 582259.905% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 11055.787% |
| Ainos, Inc. | -253.73 Thousand USD | 153426.528% |
| Pluri Inc. | 322 Thousand USD | -120719.876% |
| Prothena Corporation plc | -129.2 Million USD | 401.112% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -671.538% |
| Celularity Inc. | 6.75 Million USD | -5659.289% |
| Rallybio Corporation | -150 Thousand USD | 259460.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 1293.118% |
| MeiraGTx Holdings plc | 287 Thousand USD | -135454.007% |
| Omeros Corporation | -69.77 Million USD | 657.532% |
| Humacyte, Inc. | -76.55 Million USD | 608.217% |
| Immunocore Holdings plc | 248.39 Million USD | -56.624% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 2664.704% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -523.641% |
| Blueprint Medicines Corporation | 236.58 Million USD | -64.441% |
| CalciMedica, Inc. | -58 Thousand USD | 670858.621% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 27381.907% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -1238.978% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 13779.325% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 1360.457% |
| Pulmatrix, Inc. | -8.22 Million USD | 4832.847% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 33351.282% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 97603.759% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 197.554% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -13916.505% |
| Cytokinetics, Incorporated | -322.59 Million USD | 220.598% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -45026.754% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 114187.977% |
| Vor Biopharma Inc. | -3.49 Million USD | 11240.893% |
| Roivant Sciences Ltd. | 109.23 Million USD | -256.15% |
| Evogene Ltd. | 1.39 Million USD | -27708.435% |
| ProKidney Corp. | -3.16 Million USD | 12376.428% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 985.954% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -5573.618% |
| CorMedix Inc. | -205.56 Thousand USD | 189356.769% |
| BioLineRx Ltd. | 1.1 Million USD | -35011.913% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 594.515% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 1179009.091% |
| Atai Life Sciences N.V. | -5000.00 USD | 7780900.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 319354.22% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 405350.0% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 28108.639% |
| Sagimet Biosciences Inc. | 2 Million USD | -19352.0% |
| MediciNova, Inc. | 979.7 Thousand USD | -39609.913% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 561.391% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 411543.075% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1977.537% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | -59.094% |
| Biomea Fusion, Inc. | -4.2 Million USD | 9360.652% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 55.403% |
| Mereo BioPharma Group plc | 7.42 Million USD | -5138.89% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 125596.774% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 3242100.0% |
| Absci Corporation | -41.84 Million USD | 1029.628% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 7780900.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 609.395% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 15908.208% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | -82.02% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 41443.252% |
| Allakos Inc. | -6.14 Million USD | 6435.125% |
| Imunon, Inc. | -720 Thousand USD | 54132.958% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 663.859% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 18.251% |
| BioAtla, Inc. | -103.73 Million USD | 475.047% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 3410338.429% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 218661.798% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 260.218% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 125193.248% |
| XOMA Corporation | 3.86 Million USD | -9976.146% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 655.097% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -2529.715% |
| aTyr Pharma, Inc. | -2.38 Million USD | 16391.457% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -3022.311% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 1341617.241% |
| Viridian Therapeutics, Inc. | -1 Million USD | 38695.238% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -2992615284.615% |
| Akari Therapeutics, Plc | -4000.00 USD | 9726100.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 38.916% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -199706.89% |
| UroGen Pharma Ltd. | 73.35 Million USD | -430.374% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 1557.406% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -3350804.393% |
| Orgenesis Inc. | -5.72 Million USD | 6895.459% |
| Entera Bio Ltd. | -56 Thousand USD | 694814.286% |
| GH Research PLC | -315 Thousand USD | 123604.762% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 205941.27% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 74202.857% |
| Xencor, Inc. | -85.26 Million USD | 556.298% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 176154.522% |
| Replimune Group, Inc. | -2.65 Million USD | 14753.107% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 38955.974% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | -118.754% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -199706.89% |
| Portage Biotech Inc. | -54 Thousand USD | 720544.444% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 411543.075% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 103293.634% |
| OncoCyte Corporation | 413 Thousand USD | -94098.547% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 8655049.944% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 175243343.243% |
| Purple Biotech Ltd. | -196 Thousand USD | 198589.796% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -4238.091% |
| scPharmaceuticals Inc. | 9.78 Million USD | -3877.101% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 3824.668% |
| HilleVax, Inc. | -2.15 Million USD | 18144.527% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 401172.165% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 2593008.558% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 58339.521% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 1691578.261% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 5183043.076% |
| Savara Inc. | -44.26 Million USD | 978.948% |
| Curis, Inc. | 9.81 Million USD | -3865.345% |
| Daré Bioscience, Inc. | 2.76 Million USD | -13947.189% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 311860.746% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 22600.868% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 170731.579% |
| BeiGene, Ltd. | 2.07 Billion USD | 81.286% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 14014.661% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 197.342% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -586.283% |
| Erasca, Inc. | -3.73 Million USD | 10524.437% |
| bluebird bio, Inc. | -4.03 Million USD | 9753.598% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 1378794.45% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 79.571% |
| DBV Technologies S.A. | 15.72 Million USD | -2373.55% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 1378794.45% |
| Moderna, Inc. | 2.15 Billion USD | 81.947% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 42618.033% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -4759.355% |
| Molecular Templates, Inc. | 50.39 Million USD | -671.981% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 72682.09% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -190.788% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 6352.652% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 1088.842% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 450.083% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 10942.809% |
| MacroGenics, Inc. | 50.52 Million USD | -669.965% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 6479.797% |
| Prime Medicine, Inc. | -147.9 Million USD | 363.034% |
| Aditxt, Inc. | -111.66 Thousand USD | 348514.831% |
| Adagene Inc. | 18.11 Million USD | -2048.029% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -79621.311% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | -177.485% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | -146.484% |
| SciSparc Ltd. | 2.19 Million USD | -17615.847% |
| Vericel Corporation | 135.57 Million USD | -186.953% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 1553215.893% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 1255796.856% |
| Generation Bio Co. | -73.91 Million USD | 626.363% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 89125.172% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -612.28% |
| Invivyd, Inc. | -2.02 Million USD | 19283.432% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 229.317% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 376209.36% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -303.702% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -295.816% |
| ADMA Biologics, Inc. | 88.21 Million USD | -340.998% |
| Clene Inc. | 533 Thousand USD | -72890.619% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -1513.659% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 40752.038% |
| GeoVax Labs, Inc. | -20.72 Million USD | 1977.537% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -19469.416% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 200309.967% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -681.126% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 5585.618% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 46635.885% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -366.391% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -532015.111% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -631.801% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 324.635% |
| Trevena, Inc. | 1.45 Million USD | -26638.144% |
| Surrozen, Inc. | -27.23 Million USD | 1528.718% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 110309.632% |
| Cingulate Inc. | -582.91 Thousand USD | 66840.09% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 1255067.742% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 2074.923% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 5139333.818% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 44258.91% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 42.848% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 39476.518% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 690597.32% |
| Kronos Bio, Inc. | 1.37 Million USD | -28255.685% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 824.928% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 133332.877% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 79770.048% |
| ImmunityBio, Inc. | -17.89 Million USD | 2274.623% |
| Korro Bio, Inc. | -3.63 Million USD | 10817.355% |
| Kineta, Inc. | 5.43 Million USD | -7060.685% |
| BioVie Inc. | -229.37 Thousand USD | 169707.24% |
| Codexis, Inc. | 57.33 Million USD | -578.55% |
| Celularity Inc. | 6.75 Million USD | -5659.289% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -9594.493% |
| Celcuity Inc. | -142.77 Thousand USD | 272590.404% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -768905.732% |
| Cibus, Inc. | 1.42 Million USD | -27258.65% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 104121.39% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 1797.456% |
| IN8bio, Inc. | -2.5 Million USD | 15655.378% |
| Kodiak Sciences Inc. | -25.94 Million USD | 1599.364% |
| Annexon, Inc. | -3.26 Million USD | 12008.173% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 19133.268% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 1032.123% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -60687.5% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 50.028% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | -124.937% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 20575.789% |
| Arcellx, Inc. | 108.27 Million USD | -259.294% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 1301.891% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -391.187% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 1939.259% |
| Moolec Science SA | -143.3 Thousand USD | 271576.92% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 1019.325% |
| Geron Corporation | -123.5 Million USD | 415.004% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -11735.716% |
| Royalty Pharma plc | 1.79 Billion USD | 78.313% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 655.058% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 10770864.12% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -168030.999% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 449.184% |
| Humacyte, Inc. | -76.55 Million USD | 608.217% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 41087.216% |
| 89bio, Inc. | -273 Thousand USD | 142605.495% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 31049.881% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 45977.358% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 316392.683% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -34666.756% |
| Notable Labs, Ltd. | 113 Thousand USD | -344183.186% |
| Liquidia Corporation | 14.6 Million USD | -2564.658% |
| Mustang Bio, Inc. | -2.22 Million USD | 17584.944% |
| Immunovant, Inc. | -231 Thousand USD | 168515.584% |
| Quantum-Si incorporated | 488 Thousand USD | -79621.311% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 800.229% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 1296900.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -20793.663% |
| Acasti Pharma Inc. | -11 Thousand USD | 3536827.273% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 190230.83% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 60095.004% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 332.246% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -34189.341% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 102210.236% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 19969.254% |
| PepGen Inc. | -1.18 Million USD | 32958.108% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 306430.709% |
| United Therapeutics Corporation | 2.07 Billion USD | 81.206% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 1799.087% |
| Solid Biosciences Inc. | -76.56 Million USD | 608.131% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 471189.692% |
| Immuneering Corporation | -764.13 Thousand USD | 51012.27% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -587006.121% |
| Belite Bio, Inc | -399 Thousand USD | 97603.759% |
| XOMA Corporation | 3.86 Million USD | -9976.146% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 2041.705% |
| Bionomics Limited | -434.44 Thousand USD | 89647.91% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 36323.464% |
| uniQure N.V. | 2.21 Million USD | -17463.883% |
| Cassava Sciences, Inc. | -89.42 Million USD | 535.056% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 522.553% |
| Forte Biosciences, Inc. | -9000.00 USD | 4322766.667% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 46691.617% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 89125.172% |
| Altimmune, Inc. | -65.37 Million USD | 695.108% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | -7.461% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 36323.464% |
| Compugen Ltd. | 31.45 Million USD | -1136.814% |
| Peak Bio, Inc. | 367.76 Thousand USD | -105683.794% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -1486.882% |
| Benitec Biopharma Inc. | 108 Thousand USD | -360122.222% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 498869.231% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 32439.152% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 21452.36% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 327024.37% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 32439.152% |
| Instil Bio, Inc. | -4.75 Million USD | 8279.983% |
| argenx SE | 1.1 Billion USD | 64.903% |
| Immunome, Inc. | -8.9 Million USD | 4467.801% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 20684.127% |
| Verona Pharma plc | -679.62 Thousand USD | 57343.417% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 222408.571% |
| Shattuck Labs, Inc. | -2.38 Million USD | 16411.95% |
| CervoMed Inc. | -1.29 Million USD | 30173.584% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 16262.858% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 8244.023% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -15644.233% |
| Moolec Science SA | -143.3 Thousand USD | 271576.92% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 95445.93% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 14662.453% |
| AnaptysBio, Inc. | 14.78 Million USD | -2532.028% |
| Design Therapeutics, Inc. | -537 Thousand USD | 72546.927% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 91210.07% |
| NeurAxis, Inc. | 2.15 Million USD | -17938.637% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -18028.611% |
| Lumos Pharma, Inc. | 2 Million USD | -19284.155% |
| Achilles Therapeutics plc | -4.73 Million USD | 8322.745% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 222408.571% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 368247.622% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -1128.854% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -45026.754% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 37797.674% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 954.132% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -904644.186% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 47428.467% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 2956780.347% |
| Palisade Bio, Inc. | 246 Thousand USD | -158046.341% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 1179009.091% |
| Beam Therapeutics Inc. | -59.67 Million USD | 751.964% |
| Neurogene Inc. | -3.26 Million USD | 12026.426% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | -179.212% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 10637.378% |
| Sesen Bio, Inc. | 40 Million USD | -872.6% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 131089.899% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 9760.701% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 4166.904% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -2663.068% |
| Athira Pharma, Inc. | -969 Thousand USD | 40248.607% |
| Vaccinex, Inc. | -16 Million USD | 2530.892% |
| HCW Biologics Inc. | -574.82 Thousand USD | 67779.846% |
| XOMA Corporation | 3.86 Million USD | -9976.146% |
| Nektar Therapeutics | 53.47 Million USD | -627.477% |
| Arvinas, Inc. | 71.8 Million USD | -441.838% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 566.134% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 719.737% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 120919.876% |
| Rezolute, Inc. | -36 Thousand USD | 1080766.667% |
| Clene Inc. | 533 Thousand USD | -72890.619% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 30299165.421% |
| BeyondSpring Inc. | 1.75 Million USD | -22118.161% |
| Synlogic, Inc. | -1.92 Million USD | 20320.374% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 1051559.459% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 6244.03% |
| Peak Bio, Inc. | 367.76 Thousand USD | -105683.794% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 2151.574% |
| Krystal Biotech, Inc. | 47.6 Million USD | -717.225% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | -175.737% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -7642.09% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 15125.38% |
| MannKind Corporation | 136.19 Million USD | -185.658% |
| Ikena Oncology, Inc. | -50.49 Million USD | 870.498% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -257.528% |
| Gossamer Bio, Inc. | -4.38 Million USD | 8972.064% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 154480.952% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 7780900.0% |
| Legend Biotech Corporation | 140.92 Million USD | -176.054% |
| Mural Oncology plc | -2.56 Million USD | 15255.434% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 70706.171% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 389140.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -1774.53% |
| REGENXBIO Inc. | 53.02 Million USD | -633.636% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 7362.337% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 202330.019% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 22561.894% |
| Vaxart, Inc. | -60.76 Million USD | 740.258% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 148147.797% |
| Cellectis S.A. | 18 Thousand USD | -2161233.333% |
| Longeveron Inc. | 221 Thousand USD | -175936.199% |
| Repare Therapeutics Inc. | -80.07 Million USD | 585.875% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 64.406% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 30164.915% |
| Revolution Medicines, Inc. | -399.66 Million USD | 197.342% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 1111642.857% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -793859.184% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 95.48% |
| Denali Therapeutics Inc. | -93.34 Million USD | 516.776% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 1553215.893% |
| Veru Inc. | 7.56 Million USD | -5042.0% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 257742.384% |
| Cingulate Inc. | -582.91 Thousand USD | 66840.09% |
| Passage Bio, Inc. | -3.72 Million USD | 10555.254% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 3230256.094% |
| Exicure, Inc. | -1.42 Million USD | 27439.424% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 101677.023% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -14292.897% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 75984.332% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -471.06% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 260141.308% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 757.096% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -99398.721% |
| OmniAb, Inc. | 14.66 Million USD | -2552.485% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -1845.881% |
| Lipocine Inc. | -2.85 Million USD | 13746.609% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 21209.061% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 6919.281% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 25927.679% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -416.544% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 598623.077% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -361.517% |
| Ocugen, Inc. | -33.53 Million USD | 1260.032% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 12403.605% |
| Q32 Bio Inc. | 578 Thousand USD | -67207.958% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 146907.547% |
| Alumis Inc. Common Stock | -1.28 Million USD | 30399.065% |
| Equillium, Inc. | 35.95 Million USD | -981.929% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 22890.861% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -77602.48% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 9410840.203% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 150308.494% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -91934.293% |
| Dominari Holdings Inc. | 2.03 Million USD | -18979.941% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 212144.41% |
| vTv Therapeutics Inc. | -13.59 Million USD | 2961.64% |
| Bio-Techne Corporation | 773.07 Million USD | 49.676% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -2146.319% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 15.57% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 33379.726% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 1722.352% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -3225.981% |
| Nkarta, Inc. | -5.86 Million USD | 6728.727% |
| BioCardia, Inc. | -7.24 Million USD | 5466.809% |
| Iterum Therapeutics plc | -1.75 Million USD | 22330.857% |